The ASEAN BioDiaspora program is a real-time web-based risk assessment tools, linking multiple datasets including air travel data, demography data of ASEAN Member States, human population density, animal populations, industrialization and utility distribution, vector locations, and other relevant datasets. The ASEAN BioDiaspora comprised of two different tools namely 1) The Explorer Tool and 2) The Insights Tool.

The Explorer Tool empowers public health with big data and advanced analytics to track and assess infectious disease threats anywhere in the world. The tool literally illustrates how disease may move around the world. Further, it demonstrates where the disease event is, the suitability of a local transmission, the factors driving disease spread, how connected the outbreak locations are with the rest of the world and what could happen if a case is imported. This web application allows users to interact with the information in a variety of ways.

The Insights Tool empowers healthcare organizations with contextualized insights about global infectious disease threats to manage risk. In addition to the Explorer information generated, Insights demonstrates which disease events are relevant to national and regional locations, the risk of disease exportation or importation, possible spread to the selected location, and disease information.

The ABVC in timely manner produced series of Risk Assessment (RA) Report for International Dissemination of COVID-19. The RA provided highlights and situational overview of the COVID-19, timeline of international dissemination, public health outlook and the risk of importation through air travel from the ground zero Wuhan as well as China to ASEAN Member States.

The RA was able provided public health officials with air-travel data volume in order to take the necessary measures for the potential dissemination of disease through the air-travel. It also provided information on cases and fatality cases related to COVID-19 and travel advisories among ASEAN Member States in response to COVID-19. 

Share This On

Related Links

Statements

Press Releases